CD4 and Cognitive impairment: To do so, future treatment strategies must be disease modifying, seeking to significantly reduce the state of chronic immune hyperactivation that exists in HIV disease and results in the loss of CD4+ T cells and the emergence of both AIDS-defining and non-AIDS complications such as cardiovascular disease, cancer, liver or kidney failure, and cognitive disorders reported in HIV-1-infected individuals receiving long-term ART.